BRAF mutation

Who we are

• January 17, 2024

  Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Refractory BRAF V600E mCRC

• April 5, 2022

  Dabrafenib + Trametinib + PDR001 In Colorectal Cancer